1 |
Henderson VW. Cognitive changes after menopause: Influence of estrogen. Clinical Obstetrics and Gynecology. 2008;51(3):618-626. https://doi.org/10.1097/GRF.0b013e318180ba10
DOI
|
2 |
Oppermann K, Fuchs SC, Donato G, Bastos CA, Spritzer PM. Physical, psychological, and menopause-related symptoms and minor psychiatric disorders in a community-based sample of Brazilian premenopausal, perimenopausal, and postmenopausal women. Menopause. 2012;19(3):355-360. https://doi.org/10.1097/gme.0b013e31822ba026
DOI
|
3 |
Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard‐dose adjuvant chemotherapy in women with breast carcinoma: Results of a prospective, randomized, longitudinal trial. Cancer. 2004;100(11):2292-2299. https://doi.org/10.1002/cncr.20272
DOI
|
4 |
Collins B, Mackenzie J, Stewart A, Bielajew C, Verma S. Cognitive effects of chemotherapy in post‐menopausal breast cancer patients 1 year after treatment. Psycho-Oncology. 2009;18(2):134-143. https://doi.org/10.1002/pon.1379
DOI
|
5 |
Lee JR, Oh PJ. Cognitive decline and quality of life among patients with breast cancer undergoing chemotherapy: The mediating effect of health promotion behavior. Korean Journal of Adult Nursing. 2016;28(2):202-212. https://doi.org/10.7475/kjan.2016.28.2.202
DOI
|
6 |
Kim JH, Oh PJ. Menopause symptoms and perceived cognitive decline in menopausal women: The mediating effect of health promotion behavior. Korean Journal of Adult Nursing. 2017;29(2):200-210. https://doi.org/10.7475/kjan.2017.29.2.200
DOI
|
7 |
Hutchinson AD, Hosking JR, Kichenadasse G, Mattiske JK, Wilson C. Objective and subjective cognitive impairment following chemotherapy for cancer: A systematic review. Cancer Treatment Reviews. 2012;38(7):926-934. https://doi.org/10.1016/j.ctrv.2012.05.002
DOI
|
8 |
Kim HJ, Kim S, Lee H, Oh SE. Factors affecting symptom experiences of breast cancer patients: Based on the theory of unpleasant symptoms. Asian Oncology Nursing. 2014;14(1):7-14. https://doi.org/10.5388/aon.2014.14.1.7
DOI
|
9 |
Kim KH, Chung BY, Kim GD, Byun HS, Choi EH, Cho EJ. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. Asian Oncology Nursing. 2012;12(1):1-11. https://doi.org/10.5388/aon.2012.12.1.1
DOI
|
10 |
Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, et al. Major depression after breast cancer: A review of epidemiology and treatment. General Hospital Psychiatry. 2008;30(2):112-126. https://doi.org/10.1016/j.genhosppsych.2007.10.008
DOI
|
11 |
Nelson CJ, Nandy N, Roth AJ. Chemotherapy and cognitive deficits: Mechanisms, findings, and potential interventions. Palliative & Supportive Care. 2007;5(3):273-280. https://doi.org/10.1017/S1478951507000442
DOI
|
12 |
Byun HS, Kim GD. Impacts of fatigue, pain, anxiety, and depression on the quality of life in patients with breast cancer. Asian Oncology Nursing. 2012;12(1):27-34. https://doi.org/10.5388/aon.2012.12.1.27
DOI
|
13 |
Luckett T, King MT, Butow PN, Oguchi M, Rankin N, Price MA, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: Issues, evidence and recommendations. Annals of Oncology. 2011;22(10):2179-2190. https://doi.org/10.1093/annonc/mdq721
DOI
|
14 |
Korea Breast Cancer Society. 2015 Breast cancer facts & figures [Internet]. Seoul: Korea Breast Cancer Society; c2015 [cited 2018 Jul 5]. Available from: http://www.kbcs.or.kr/journal/file/2015_Breast_Cancer_Facts_and_Figures_updated.pdf.
|
15 |
Brem S, Kumar NB. Management of treatment-related symptoms in patients with breast cancer. Clinical Journal of Oncology Nursing. 2011;15(1):63-71. https://doi.org/10.1188/11.CJON.63-71
DOI
|
16 |
Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. Journal of Occupational and Environmental Medicine. 2010;52(2):219-227. https://doi.org/10.1097/JOM.0b013e3181d0bef7
DOI
|
17 |
Wefel JS, Saleeba AK, Buzdar AU, Meyers CA. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer. Cancer. 2010;116(14):3348-3356. https://doi.org/10.1002/cncr.25098
DOI
|
18 |
Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FSAM. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute. 2006;98(23):1742-1745. https://doi.org/10.1093/jnci/djj470
DOI
|
19 |
Hess LM, Insel KC. Chemotherapy-related change in cognitive function: A conceptual model. Oncology Nursing Forum. 2007;34(5):981-994. https://doi.org/10.1188/07.ONF.981-994
DOI
|
20 |
Biglia N, Moggio G, Peano E, Sgandurra P, Ponzone R, Nappi RE, et al. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight. The Journal of Sexual Medicine. 2010;7(5):1891-1900. https://doi.org/10.1111/j.1743-6109.2010.01725.x
DOI
|
21 |
Vardy J, Tannock I. Cognitive function after chemotherapy in adults with solid tumours. Critical Reviews in Oncology/Hematology. 2007;63(3):183-202. https://doi.org/10.1016/j.critrevonc.2007.06.001
DOI
|
22 |
Weiss B. Evaluation of multiple neurotoxic outcomes in cancer chemotherapy. In: Raffa RB, Tallarida RJ, editors. Chemo Fog. Advances in Experimental Medicine and Biology, vol 678. New York: Springer; 2010. p. 96-112. https://doi.org/10.1007/978-1-4419-6306-2_13
|
23 |
Biegler KA, Chaoul MA, Cohen L. Cancer, cognitive impairment, and meditation. Acta Oncologica. 2009;48(1):18-26. https://doi.org/10.1080/02841860802415535
DOI
|
24 |
Bishop S, Duncan J, Brett M, Lawrence AD. Prefrontal cortical function and anxiety: Controlling attention to threat-related stimuli. Nature Neuroscience. 2004;7(2):184-188. https://doi.org/10.1038/nn1173
DOI
|
25 |
Von Ah D, Russell KM, Storniolo AM, Carpenter JS. Cognitive dysfunction and its relationship to quality of life in breast cancer survivors. Oncology Nursing Forum. 2009;36(3):326-336. https://doi.org/10.1188/09.ONF.326-334
DOI
|
26 |
Vearncombe KJ, Rolfe M, Wright M, Pachana NA, Andrew B, Beadle G. Predictors of cognitive decline after chemotherapy in breast cancer patients. Journal of the International Neuropsychological Society. 2009;15(6):951-962. https://doi.org/10.1017/S1355617709990567
DOI
|
27 |
Sarenmalm EK, Ohlén J, Jonsson T, Gaston-Johansson F. Coping with recurrent breast cancer: Predictors of distressing symptoms and health-related quality of life. Journal of Pain and Symptom Management. 2007;34(1):24-39. https://doi.org/10.1016/j.jpainsymman.2006.10.017
DOI
|
28 |
Chae MJ. A structural model for sexual function of patients with breast cancer [dissertation]. Gwangju: Chonnam National University; 2012. p. 1-133.
|
29 |
Woo JP. Understanding and concepts of structural equation model. Seoul: Hannarae Publishing Co.; 2012. p. 275-377.
|
30 |
Samarel N, Leddy SK, Greco K, Cooley ME, Torres SC, Tulman L, et al. Development and testing of the symptom experience scale. Journal of Pain and Symptom Management. 1996;12(4):221-228. https://doi.org/10.1016/0885-3924(96)00150-9
DOI
|
31 |
Heinemann K, Ruebig A, Potthoff P, Schneider HPG, Strelow F, Heinemann LAJ, et al. The menopause rating scale (MRS) scale: A methodological review. Health and Quality of Life Outcomes. 2004;2:45. https://doi.org/10.1186/1477-7525-2-45
DOI
|
32 |
Chung BY, Cho EJ. Correlates influencing cognitive impairment in breast cancer patients receiving chemotherapy. Asian Oncology Nursing. 2012;12(3):221-229. https://doi.org/10.5388/aon.2012.12.3.221
DOI
|
33 |
Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica. 1983;67(6):361-370. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
DOI
|
34 |
Oh SM, Min KJ, Park DB. A study on the standardization of the hospital anxiety and depression scale for Koreans: A comparison of normal, depressed and anxious groups. Journal of the Korean Neuropsychiatric Association. 1999;38(2):289-296.
|
35 |
Farias ST, Mungas D, Reed BR, Cahn-Weiner D, Jagust W, Baynes K, et al. The measurement of everyday cognition (ECog): Scale development and psychometric properties. Neuropsychology. 2008;22(4):531-544. https://doi.org/10.1037/0894-4105.22.4.531
DOI
|
36 |
Yoo HJ, Ahn SH, Eremenco S, Kim H, Kim WK, Kim SB, et al. Korean translation and validation of the functional assessment of cancer therapy-breast (FACT-B) scale version 4. Quality of Life Research. 2005;14(6):1627-1632. https://doi.org/10.1007/s11136-004-7712-1
DOI
|